VYNE Therapeutics Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
VYNE Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • VYNE Therapeutics Inc. Return On Equity for the quarter ending June 30, 2024 was -44 %, a 64% increase year-over-year.
  • VYNE Therapeutics Inc. annual Return On Equity for 2023 was -79.1 %, a 49.3% decline from 2022.
  • VYNE Therapeutics Inc. annual Return On Equity for 2022 was -52.9 %, a 50.3% increase from 2021.
  • VYNE Therapeutics Inc. annual Return On Equity for 2021 was -107 %, a 76.2% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -79.1 -26.1 -49.3% Jan 1, 2023 Dec 31, 2023
2022 -52.9 +53.6 +50.3% Jan 1, 2022 Dec 31, 2022
2021 -107 +342 +76.2% Jan 1, 2021 Dec 31, 2021
2020 -448 -266 -147% Jan 1, 2020 Dec 31, 2020
2019 -182 -129 -245% Jan 1, 2019 Dec 31, 2019
2018 -52.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.